Lead chemical biology efforts at Recursion to bridge multiomic discovery with target ID and design innovative chemical probes.
Posted by employer 4 days ago
First seen on Joblaze 2 days ago
Last verified on the company career page 11 hours ago
Skills & Technologies
What you'll build
Must have
Nice to have
Practical constraints
AI in the day-to-day
Recursion's AI/ML-driven Design Platform is a core tool for chemical biology decision-making.
Requirements
Not disclosed in this posting: visa sponsorship.
Benefits
Joblaze summary
The Executive Director of Chemical Biology at Recursion Pharmaceuticals is responsible for leading the development of chemical biology strategies that connect multiomic discoveries with target identification, focusing on innovative modalities like molecular glues and targeted protein degradation. This role requires extensive expertise in chemical probe design and a strong background in managing multidisciplinary teams, making it suitable for seasoned professionals with a PhD and over a decade of industry experience. The position emphasizes collaboration across various scientific disciplines, leveraging AI-driven tools to enhance drug discovery efforts.
Joblaze insights
Quick facts
From the original posting
Recursion is seeking an Executive Director of Chemical Biology to develop and lead chemical biology efforts that bridge multiomic discovery with target ID, including chemical probe design, as we expand our platform into new modalities beyond traditional small molecules (e.g. targeted protein degradation, molecular glues, and other emerging modalities). This is a senior scientific leadership role responsible for setting chemical biology strategy, managing a team of designers, and driving programs that bridge multiomic discovery to target ID and designing our chemical probe library to facilitate target discovery. .
You will lead multidisciplinary project teams: partnering closely internally with biology, multiomics platform (high content imaging, RNA etc), computational biologists and data scientists to translate novel target and ligand insights into potent, selective, and developable chemical matter. You'll bring hands-on chemical biology expertise together with the strategic judgment to prioritize programs, manage internal and external (CRO) teams, and build the new capabilities needed to establish new modalities within the portfolio.
Recursion's AI/ML-driven Design Platform is a core tool your team will draw on, and you'll play an active role in shaping how computational and generative design approaches are integrated into chemical biology decision-making. This role blends deep technical credibility with people and program leadership.
You will lead within the Drug Design team as part of the Discovery function in building Recursion's next generation of therapeutic modalities, working alongside computational drug design, medicinal chemistry, biology, data science and platform technology groups that integrate proprietary AI-driven technology with advanced molecular design. The team tackles structurally enabled and non-structurally enabled targets across a diverse range of therapeutic areas, with a growing focus on proximity (e.g. protein degradation, molecular glues), and PPI blockers (e.g. macrocycles). As a leader, you will help define how chemical biology strategy and capability is built out and scaled to impact our portfolio.
Nice to have
Working Location & Compensation:
We are open to candidates who are local or interested in moving to Salt Lake City, Utah; employees are expected to work in the office at least 50% of the time.
At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is: $237,600–$284,900. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.
#LI-ES1
#LI-REMOTE
The Values We Hope You Share:
Standard company text repeated across Recursion Pharmaceuticals's postings is omitted here.